Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
O
ONWARD Medical NV
F:63E
ONWARD Medical NV
F:63E
Price:
2.535
EUR
-0.2%
Market Closed
Market Cap:
€87.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
ONWARD Medical NV
F:63E
|
NL |
|
Gr Sarantis SA
OTC:SRTSF
|
GR |
|
Solvay SA
F:SOL0
|
BE |
|
E
|
Engro Fertilizers Ltd
KAR:EFERT
|
PK |
|
H
|
Hui Min Environmental Tech Corp
TPEX:6971
|
TW |
|
U
|
Unilever Indonesia Tbk PT
XMUN:UTG
|
ID |
|
I
|
ICON PLC
F:IJF
|
IE |
Wall St Price Targets
63E Price Forecast
Based on 8 analysts
Based on 8 analysts
+444% Upside
from
€2.535
today
ONWARD Medical NV (63E)’s 12-month stock price forecast through October 2027 has a consensus target of €13.782, implying 444% upside. The forecast is based on price targets from 8 Wall Street analysts.
ONWARD Medical NV Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 63E's stock price target?
Price Target
13.782
EUR
13.782
EUR
According to Wall Street analysts, the average 1-year price target for 63E is 13.782 EUR with a low forecast of 12.705 EUR and a high forecast of 17.937 EUR.
What is the Revenue forecast for ONWARD Medical NV?
Projected CAGR
139%
139%
The compound annual growth rate for Revenue over the next 3 years is 139%.
What is the Gross Profit forecast for ONWARD Medical NV?
Projected CAGR
137%
137%
The compound annual growth rate for Gross Profit over the next 3 years is 137%.